期刊文献+

长春地区丙型肝炎病毒的基因分型及其与肝脏疾病的相关性 被引量:6

Genotyping of Hepatitis C Virus in Changchun Region,China and Relationship between HCV Genotype and Severity of Liver Diseases
原文传递
导出
摘要 目的分析长春地区丙型肝炎病毒(HCV)基因型的分布及其与HCV RNA含量、感染途径、肝病程度的相关性。方法采用荧光定量PCR和型特异性引物PCR对82份抗-HCV阳性病人的血清标本进行HCV RNA检测及HCV的基因分型,并分析基因型与感染途径、HCV RNA含量和肝病程度的相关性。结果78份HCV RNA阳性血清标本中1a型占5.1%、1b型占48.7%、2a型占33.3%、2b型占11.6%、3a型占1.3%,未发现混合型。血源性与非血源性感染患者间HCV基因型构成比差异无统计学意义。基因1b型的HCV RNA含量高于2a型,且差异有统计学意义。HCV感染的不同程度肝病患者的基因型分布差异有统计学意义,基因1b型比率显著高于其他基因型。结论长春地区丙型肝炎病毒基因型流行株为1b和2a型;HCV基因型与感染途径无明显相关性;基因lb型的病毒含量明显高于2a型;HCV基因型与慢性丙型肝炎的严重程度及肝硬化、肝癌的产生有一定的相关性。 Objective To analyze the distribution of hepatitis C virus (HCV) genotype in Changchun Region, China and its relationship to HCV RNA content as well as infectious route and degree of liver disease. Methods The serum specimens from 82 anti-HCV patients were determined for HCV RNA by fluorescent quantitative PCR, and analyzed for HCV genotype by PCR using type-specific primers, based on which the relationship of genotype to infectious route, HCV RNA content and degree of liver disease was analyzed. Results Of the 78 HCV RNA-positive serum specimens, 4(5. 1%) were identified as genotype 1a, 38(48.7%) as 1 b, 26 (33. 3%) as 2a, 9(11.6%) as 2b, and 1 (1.3%) as 3a. No mixed infection of HCV of various genotypes was observed. No significant difference was observed in the distributions of HCV genotypes in the patients with blood-transmitted and non-blood-transmitted hepatitis C. The RNA content of HCV of genotype lb was significantly higher than that of genotype 2a. However, the distribution of genotypes showed significant difference in the patients with liver diseases at various degrees caused by HCV infection. The proportions of genotype lb in patients with chronic hepatitis C, liver cirthosis and liver cancer were significantly higher than those of other genotypes. Conclusion The epidemie HCV strains in Changehun Region were of genotypes lb and 2a. No significant relationship was observed between HCV genotype and infectious route. The HCV content of genotype lb was significantly higher than that of genotype 2a. HCV genotype showed a certain relationship to the severity of chronic hepatitis C and the onsets of liver cirthosis and liver cancer.
出处 《中国生物制品学杂志》 CAS CSCD 2009年第1期35-37,共3页 Chinese Journal of Biologicals
关键词 丙型肝炎病毒 基因分型 感染途径 病毒含量 肝病 Hepatitis C virus Genotype Infectious route Viral content Liver disease
  • 相关文献

参考文献12

  • 1Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis, 2005, 5(9): 558-567.
  • 2杨银辉.病毒基因分型方法的研究进展及应用[J].中华检验医学杂志,2005,28(10):1102-1104. 被引量:7
  • 3Viazov S, ZibertA, Ramakrishnan K, et al. Typing of hepatitis C virus isolates by DNA enzyme immunoassay. J Virol Methods, 1994, 48(1): 81-91.
  • 4Zein NN. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev, 2000, 13(2): 223-235.
  • 5Seeff LB, Hoofnagle JH. Appendix: The national institutes of health consensus development conference management of hepatitis C 2002. Clin Liver Dis, 2003, 7( 1 ): 261-287.
  • 6苏英豪.丙型肝炎病毒基因分型及其意义:近3年的研究进展[J].国外医学(微生物学分册),1999,22(1):8-11. 被引量:20
  • 7Dhingra N. Blood safety in the developing world and WHO initiatives. Vox Sang, 2002,83 (Suppl 1 ) : 173-177.
  • 8谢尧,赵辉,鸥蔚妮,闫杰,杜邵财,徐道振.不同感染途径慢性丙型肝炎患者HCV基因型分布的差异[J].中华实验和临床病毒学杂志,2004,18(3):247-250. 被引量:30
  • 9Belden H. Hepatitis C treatments show early promise. Drug Topics, 2006, 150(9): 22-40.
  • 10Yamada G,Takahashi M,Tsuji T, et al. Quantitative HCV RNA and effect of interferon therapy in chronic hepatitis C. Dig Dis Sci, 1992, 37( 12): 1926-1927.

二级参考文献20

  • 1杜绍财,陶其敏.丙型肝炎病毒基因5‘—末端非编码区酶切分型研究[J].中华医学杂志,1993,73(1):7-9. 被引量:45
  • 2Miyakawa Y, Okamoto H, Mayumi M. Classifying hepatitis C virus genotypes. Mol Med Today, 1995,1:20-25.
  • 3Gallegos-Orozco JF, Fuentes AP, Olivera-Martinez MA, et al. Early HCV RNA changes in patients with chronic hepatitis C treated with peginterferon alfa 2b and ribavirin. Rev Invest Clin, 2003,55:138-142.
  • 4Inoue K, Sekiyama K, Yamada M, et al. Combined interferon alpha 2b and cyclosporin A in the treatment of chronic hepatitis C: controlled trial. J Gastroenterol, 2003,38:567-572.
  • 5Berg T, Kronenberger B, Hinrichsen H. Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trial. Hepatology, 2003,37:1359-1367.
  • 6Baker DE. Pegylated interferon plus ribavirin for the treatment of chronic hepatitis C. Rev Gastroenterol Disord, 2003,3:93-109.
  • 7Sugo H, Balderson GA, Crawford DHG, et al. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today, 2003,33:421-425.
  • 8Farci P, Purcell RH. Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis, 2000, 1:103-126.
  • 9Bukh J, Puecell RH, Miller RH. At least 12 genotypes of hepatitis C virus predicted by sequence analysus of the putative E1 gene of isolates collected worldwide. Proc Natl Acad Sci U S A, 1993,90:9234-8238.
  • 10Simmonds P, Holmes EC, Cha TA, et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of NS-5 region. J Gen Virol, 1993,74:2391-2399.

共引文献52

同被引文献44

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部